successful transition to sulphonylurea therapy from insulin in a child with permanent neonatal diabetes due to a kcnj11 gene mutation

successful transition to sulphonylurea therapy from insulin in a child with permanent neonatal diabetes due to a kcnj11 gene mutation

;Venkatesan Radha;Bhuvanagiri Ramya;Sundaramoorthy Gopi;Babu Kavitha;Somayajula Preetika;Kalpana Thai;Ranjit Unnikrishnan;Viswanathan Mohan;Prasanna Kumar Gupta
journal of diabetology 2018 Vol. 9 pp. 65-67
156
radha2018journalsuccessful

Abstract

Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes mellitus that occurs in the first 6 months of life. It is a rare condition with a prevalence of 1 in 100,000–500,000 live births. We report a 3-month-old girl child with high blood glucose levels. She was diagnosed with diabetes mellitus during the 28th day of life and was on treatment with insulin. She was admitted for the control of high blood glucose levels during which she was started on multiple daily insulin treatment, but the control had been poor. As the age of onset is <6 months of life, genetic analysis has been done. It revealed the presence of a heterozygous mutation p. Gly334Val (p. G334V) in KCNJ11 gene which confirmed the diagnosis of NDM. The child was successfully shifted from insulin to sulfonylureas, and the blood glucose levels are well maintained.

Citation

ID: 137960
Ref Key: radha2018journalsuccessful
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
137960
Unique Identifier:
10.4103/jod.jod_37_17
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet